Komori
Revision of earnings forecasts3645Medical Net,Inc.Information and Communications, Services and Others

Notice Concerning the Difference between the Consolidated Earnings Forecast and Actual Results for the Second Quarter (Cumulative) of the Fiscal Year Ended May 2024

For the six months ended November 2023, revenue was 4.3% below forecast, while operating profit, ordinary profit and profit attributable to owners of the parent for the period exceeded forecast by 35.8%, 70.2% and 86.7%, respectively.

Worth reading
61In focus
0–100. This measures how worthwhile something is to read, not how good or bad the company is.
Direction
Mixed performance
Direction inferred from the company’s description.
Scale
86.7
%
Wording
Definitive
How definitive the wording is.

Revised forecast

2024 年5月期 · Cumulative second quarterPrevious forecast published 2023 年7月 18 日
Net Sales2,448→2,342million
-4.3%
Operating profit125→169million
+35.8%
Ordinary income114→194million
+70.2%
Profit attributable to owners of the parent62→115million
+86.7%
Net income per share6.88→12.8yen and sen
+86.0%

The bar length represents the relative magnitude of change, based on the item that changed the most in this document. The percentage change shown by the dotted line is calculated from the two reported figures because the company did not provide the rate.

Reason for the revision

メディア・プラットフォーム事業における新サービスの受注好調、医療BtoB事業における利益率の高いサービスの販売好調、営業利益の増加、為替相場の変動に伴う為替差益25百万円の計上など。

Previous-period resultsNet Sales 1,997 売上高・営業利益・経常利益・親会社株主に帰属する四半期純利益:百万円、1株当たり四半期純利益:円 銭 / Operating profit 177 売上高・営業利益・経常利益・親会社株主に帰属する四半期純利益:百万円、1株当たり四半期純利益:円 銭 / Ordinary income 205 売上高・営業利益・経常利益・親会社株主に帰属する四半期純利益:百万円、1株当たり四半期純利益:円 銭 / Profit attributable to owners of parent for the quarter 116 売上高・営業利益・経常利益・親会社株主に帰属する四半期純利益:百万円、1株当たり四半期純利益:円 銭 / Net income per share for the quarter 13.09 売上高・営業利益・経常利益・親会社株主に帰属する四半期純利益:百万円、1株当たり四半期純利益:円 銭
Consolidated / non-consolidatedConsolidated
Revised forecast
ItemDetails
Net Sales¥2,448 million → ¥2,342 million(-4.3%)
Operating profit¥125 million → ¥169 million(+35.8%)
Ordinary income¥114 million → ¥194 million(+70.2%)
Profit attributable to owners of the parent¥62 million → ¥115 million(+86.7%)
Net income per share6.88 yen and sen → 12.80 yen and sen
Fiscal Period Covered2024 年5月期
Period CoveredCumulative second quarter
Publication date of previous forecast2023 年7月 18 日
Previous-period resultsNet Sales 1,997 売上高・営業利益・経常利益・親会社株主に帰属する四半期純利益:百万円、1株当たり四半期純利益:円 銭 / Operating profit 177 売上高・営業利益・経常利益・親会社株主に帰属する四半期純利益:百万円、1株当たり四半期純利益:円 銭 / Ordinary income 205 売上高・営業利益・経常利益・親会社株主に帰属する四半期純利益:百万円、1株当たり四半期純利益:円 銭 / Profit attributable to owners of parent for the quarter 116 売上高・営業利益・経常利益・親会社株主に帰属する四半期純利益:百万円、1株当たり四半期純利益:円 銭 / Net income per share for the quarter 13.09 売上高・営業利益・経常利益・親会社株主に帰属する四半期純利益:百万円、1株当たり四半期純利益:円 銭
Reason for the revisionメディア・プラットフォーム事業における新サービスの受注好調、医療BtoB事業における利益率の高いサービスの販売好調、営業利益の増加、為替相場の変動に伴う為替差益25百万円の計上など。
Consolidated / non-consolidatedConsolidated
Items this document does not state (2)
Details and amount of extraordinary lossDividend forecast revision

These are items the company does not state in this document. We do not leave them blank, nor fill them in from other sources or by inference.

The reasons the company gives

The company's own explanation, not something inferred from the numbers.

メディア・プラットフォーム事業で新サービスの受注が好調に推移し、医療BtoB事業で利益率の高いサービスの販売が好調だったため営業利益が予想を上回りました。経常利益と親会社株主に帰属する四半期純利益は、営業利益の増加に加え、為替差益25百万円を計上したことなどにより予想を上回りました。

How to read this page

This is not the documentKomori reads the disclosure the company filed and writes this summary. Figures are as stated by the company and are not audited.
Weight is not a verdictIt measures how much this changes what the company had already told the market. It is not a view on the shares.
Corrections happenIf the company reissues this disclosure, the page is rebuilt from the corrected version and the revision number moves up.
Notice Concerning the Difference between the Consolidated Earnings Forecast and Actual Results for the Second Quarter (Cumulative) of the Fiscal Year Ended May 2024 | Medical Net,Inc. (3645) timely disclosure | Komori